Αποτελέσματα Αναζήτησης
12 Αυγ 2020 · Cancer and its treatment can have profound effects on bone health. Clinicians treating cancer patients need to be aware of the multidisciplinary treatments available to reduce skeletal morbidity from metastatic disease and minimise cancer treatment-induced damage to the normal skeleton.
- ABC 5
For the purpose of advanced breast cancer (ABC) guidelines,...
- Fertility Preservation and Post-Treatment Pregnancies in Post-Pubertal Cancer Patients
These guidelines provide a framework for fertility...
- ABC 5
18 Δεκ 2018 · What is bone metastasis? When a cancer spreads to the bones, it’s called bone metastasis. It’s also called metastatic bone disease or secondary bone cancer, because the cancer...
Some people also have hormone therapy after chemotherapy for breast cancer or endometrial cancer. The drugs suppress production of estrogen, a hormone that plays an important role in metabolism. If your metabolism slows down, you may put on weight.
Hormone therapy. Hormone therapy, also called endocrine therapy, may be used to treat breast or prostate cancer that has spread to the bone. Synthetic hormones which have been produced in a laboratory are given as tablets or injections to slow or stop the effect of the body’s natural hormones.
Types of treatment for secondary bone cancer. You may have one or more of the following treatments for secondary bone cancer. Hormone therapy . Some cancers including breast and prostate cancer depend on hormones to survive and grow. So lowering hormone levels in the body can help to control them.
20 Μαρ 2018 · Endocrine therapy, a mainstay treatment in the management of patients with hormone-sensitive breast and prostate cancer in the adjuvant setting, commonly exerts adverse effects on the musculoskeletal system and is associated with an increased risk of osteoporosis and fractures.
Bisphosphonates and denosumab prevent bone loss associated with use of ovarian suppression or aromatase inhibitors in early breast cancer and androgen deprivation therapy in prostate cancer (I,B). Bone metastases
